JP Morgan Chase’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.13K Buy
600
+599
+59,900% +$12.7K ﹤0.01% 6883
2025
Q4
$29 Hold
1
﹤0.01% 7279
2025
Q3
$78 Sell
1
-4
-80% -$1.98K ﹤0.01% 7191
2025
Q2
$1.13K Buy
5
+4
+400% +$780 ﹤0.01% 6610
2025
Q1
$344 Hold
1
﹤0.01% 6736
2024
Q4
$416 Hold
1
﹤0.01% 6822
2024
Q3
$228 Hold
1
﹤0.01% 6893
2024
Q2
$248 Hold
1
﹤0.01% 6761
2024
Q1
$274 Hold
1
﹤0.01% 6776
2023
Q4
$217 Hold
1
﹤0.01% 7039
2023
Q3
$276 Hold
1
﹤0.01% 6801
2023
Q2
$569 Hold
1
﹤0.01% 6531
2023
Q1
$0 Sell
1
-10
-91% -$8.72K ﹤0.01% 6975
2022
Q4
$21K Buy
11
+10
+1,000% +$3.96K ﹤0.01% 5867
2022
Q3
$0 Hold
1
﹤0.01% 6665
2022
Q2
$0 Sell
1
-21
-95% -$32.9K ﹤0.01% 6683
2022
Q1
$77K Sell
22
-2
-8% -$5.24K ﹤0.01% 5620
2021
Q4
$73K Sell
24
-6
-20% -$27.8K ﹤0.01% 5803
2021
Q3
$195K Sell
30
-3
-9% -$25.9K ﹤0.01% 5245
2021
Q2
$433K Buy
33
+1
+3% +$15.7K ﹤0.01% 4781
2021
Q1
$533K Sell
32
-1
-3% -$19.5K ﹤0.01% 4637
2020
Q4
$567K Sell
33
-35
-51% -$659K ﹤0.01% 4294
2020
Q3
$1.35M Buy
68
+27
+66% +$621K ﹤0.01% 3472
2020
Q2
$1.09M Buy
41
+5
+14% +$142K ﹤0.01% 3461
2020
Q1
$792K Sell
36
-52
-59% -$831K ﹤0.01% 3559
2019
Q4
$811K Sell
88
-17
-16% -$164K ﹤0.01% 3986
2019
Q3
$997K Buy
105
+2
+2% +$24.3K ﹤0.01% 3839
2019
Q2
$1.51M Sell
103
-3
-3% -$49.7K ﹤0.01% 3564
2019
Q1
$2.19M Buy
106
+3
+3% +$53.3K ﹤0.01% 3264
2018
Q4
$1.25M Buy
103
+39
+61% +$676K ﹤0.01% 3603
2018
Q3
$1.58M Buy
64
+17
+36% +$518K ﹤0.01% 3625
2018
Q2
$1.6M Sell
47
-34
-42% -$1.3M ﹤0.01% 3554
2018
Q1
$3.18M Sell
81
-9
-10% -$342K ﹤0.01% 2940
2017
Q4
$4.15M Buy
90
+20
+29% +$936K ﹤0.01% 2827
2017
Q3
$4.04M Buy
+70
New +$3.84M ﹤0.01% 2716

Other funds holding KALA

JP Morgan Chase's KALA Position: Q1 2026 in Review

JP Morgan Chase increased its KALA BIO (KALA) stake by 59,900% in Q1 2026, buying an estimated $12.7K and bringing the position to 600 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #6883.

JP Morgan Chase first reported a position in KALA in Q3 2017 and has held it in 35 quarters since. The position peaked at $4.15M in Q4 2017. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • JP Morgan Chase held 600 shares of KALA BIO worth $5.13K as of Q1 2026.
  • JP Morgan Chase bought 599 KALA BIO shares in Q1 2026, an estimated $12.7K.
  • KALA BIO made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6883 holding.
  • JP Morgan Chase first reported a position in KALA BIO in Q3 2017 and has held it in 35 quarters since.
  • JP Morgan Chase's KALA BIO position peaked at $4.15M in Q4 2017.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.